NCT06412198 2026-03-06A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C MutationsM.D. Anderson Cancer CenterPhase 1/2 Recruiting31 enrolled